PP_1170x120_10-25-21

Bryan Downey

Alfasigma announces that Zelnorm now available in the U.S. to treat IBS in adult women

Alfasigma announces that Zelnorm now available in the U.S. to treat IBS in adult women

BEDMINSTER, N.J. — Alfasigma USA announced Friday that Zelnorm (tegaserod) is now available in the United States as a prescription pharmaceutical treatment for irritable bowel syndrome with constipation (IBS-C) in adult women less than 65 years of age. Alfasigma USA acquired Zelnorm from Sloan Pharma S.à r.l., a subsidiary of US WorldMeds Holdings, in July

Adheris Health